Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fautrel, B.
Right arrow Articles by Penrod, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fautrel, B.
Right arrow Articles by Penrod, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Costs of Rheumatoid Arthritis: New Estimates from the Human Capital Method and Comparison to the Willingness-to-Pay Method

Bruno Fautrel, MD, PhD

Department of Rheumatology, University of Paris VI-Pierre et Marie Curie, Hospital Pitié-Salpêtrière, Paris, France, Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, EA 3444, School of Public Health, Faculty of Medicine, Nancy, France, bruno.fautrel{at}psl.ap-hop-paris.fr

Ann E. Clarke, MD, MSc

Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada

Francis Guillemin, MD, PhD

EA 3444, School of Public Health, Faculty of Medicine, Nancy, France

Viviane Adam, MSc

Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada

Yvan St-Pierre, MSc

Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada

Tina Panaritis, BSc

Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada

Paul R. Fortin, MD, MSc

Department of Rheumatology, University of Toronto, Toronto, ON, Canada

Henri A. Menard, MD

Department of Rheumatology, McGill University Health Center, Montreal, QC, Canada

Cam Donaldson, PhD

Institute of Health and Society, University of Newcastle, UK

John R. Penrod, PhD

Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada

Background . Individuals' valuation of changes in health states in monetary terms have been measured by examining changes in the direct and indirect costs of disease and by the willingness-to-pay (WTP) methodology. Methods . In 2002, a 2-part study was conducted in Quebec. In one part of the study, 121 rheumatoid arthritis (RA) patients from the McGill University Health Centre were mailed the Stanford Cost Assessment Questionnaire, which enabled the elicitation of direct costs and indirect costs, according to the friction cost and the human capital methods. The other part was a phone survey conducted in a representative sample of the general population and in the same sample of patients, aiming to elicit the societal WTP for a complete cure of RA in the context of 2 different scenarios: a public coverage or private insurance. These estimates were then compared. Results. Estimates of the cost of illness of RA ranged from 11,717 to 28,498 Canadian Dollars (CAD) depending on the method. These estimates are higher than those previously published in Canada from the 1990s, which is partly due to the recent and costly biological therapies and to a change in the measurement of productivity losses. These estimates are somewhat lower than the societal WTP elicited from the WTP survey, that is, 26,717 and 36,817 CAD per RA case, depending on the public or private health insurance context in which the cure would be available. Conclusion. Given that neither method is ideal, data from both methods would provide an important sensitivity analysis when monetary estimates of health state changes are required.

Key Words: willingness to pay • cost of illness • rheumatoid arthritis • human capital • friction cost

Medical Decision Making, Vol. 27, No. 2, 138-150 (2007)
DOI: 10.1177/0272989X06297389


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
A. T. JOYCE, P. SMITH, R. KHANDKER, J. M. MELIN, and A. SINGH
Hidden Cost of Rheumatoid Arthritis (RA): Estimating Cost of Comorbid Cardiovascular Disease and Depression Among Patients with RA
J Rheumatol, April 1, 2009; 36(4): 743 - 752.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. S. Lee, M. H. Pittler, and E. Ernst
Tai chi for rheumatoid arthritis: systematic review
Rheumatology, November 1, 2007; 46(11): 1648 - 1651.
[Abstract] [Full Text] [PDF]